| Literature DB >> 29191174 |
Xiaonan Xue1, Ilir Agalliu2, Mimi Y Kim2, Tao Wang2, Juan Lin2, Reza Ghavamian3, Howard D Strickler2.
Abstract
BACKGROUND: The follow-up rate, a standard index of the completeness of follow-up, is important for assessing the validity of a cohort study. A common method for estimating the follow-up rate, the "Percentage Method", defined as the fraction of all enrollees who developed the event of interest or had complete follow-up, can severely underestimate the degree of follow-up. Alternatively, the median follow-up time does not indicate the completeness of follow-up, and the reverse Kaplan-Meier based method and Clark's Completeness Index (CCI) also have limitations.Entities:
Keywords: Competing risk; Loss to follow-up; Median survival time; Person-time; Reverse Kaplan-Meier survival curve
Mesh:
Year: 2017 PMID: 29191174 PMCID: PMC5709923 DOI: 10.1186/s12874-017-0436-z
Source DB: PubMed Journal: BMC Med Res Methodol ISSN: 1471-2288 Impact factor: 4.615
Fig. 1Illustration of the differences in estimates of follow-up using existing and proposed methods. The figure depicts a hypothetical cohort of 100 subjects who were followed and assessed with annual visits for three years. There were 10, 5 and 5 outcome events in the 1st, 2nd and 3rd, respectively. There were 40 dropouts in the 1st year in scenario (A) and in the 3rd year in scenario (B). For simplicity, in this example all events and dropouts occurred on average at the middle of the year. Because the calculation of the true person-time follow-up rate requires the knowledge of the event time for dropouts, we further assumed two situations for the 40 dropouts: (1) none of them became events during the study and (2) 5 of them became events shortly after they dropped out. The Percentage Method (see Eq. (1)) estimates follow-up as the same in both scenarios, since it does not account for person-time in a cohort, and in essence assumes that all dropout occurs at the beginning of the study. Conversely, the Clark Completeness Index (see Eq. (2)) and the Simplified Person-Time Method (see Eq. (5)) both address person-time and provide accurate estimates of the True Person-Time Follow-up Rate (see Eq. (3)). The calculations for each method are shown based on the data from the two scenarios depicted above
Fig. 2Illustration of the Reverse Kaplan-Meier Survival Curve for follow-up rate. The figure depicts a hypothetical cohort of 100 subjects who were followed for two years, there were 30 outcome events in the 1st year in scenario (A) and 10 outcome events in the 1st year in scenario (B) while in both scenarios there was no dropout in the 1st year and 30 dropouts in the 2nd year. The dashed dotted line describes the reverse KM follow-up rate for scenario (A), the dashed line describes the reverse KM follow-up rate for scenario (B) and the solid line describes the follow-up rate after treating outcome events as competing events. While scenario (A) and (B) have the exactly the same level and timing of dropouts, scenario (A) has a lower follow-up rate simply because it has more earlier events; both scenarios share the same follow-up rate after addressing competing risk. Note: this is not the KM curve for the outcome events. In this plot, losses to follow-up were treated as “events” while development of outcome events were treated as “censored”
Follow-up rates under varying assumptions estimated using four methods: (i) the standard Percentage Method (Eq. 1), (ii) the Clark’s Completeness Index (CCI, Eq. 2), (iii) the Person-Time Method estimated using the formal method (FPT, Eq. 4) and (iv) the Simplified Person-Time Method (SPT, Eq. 5)
| Assumed event rate | True Person-time follow-up rate | Percentage Method | Estimated using the formal method | Clark’s compleness inex | Simplified Person-time method | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Average | %bias1 |
| Average | %bias |
| Average | %bias |
| Average | %bias |
| ||
| 5% | 95.0% | 90.4% | −4.90 | .047 | 95.0% | 0.00 | .001 | 94.9% | −0.08 | .001 | 95.1% | 0.05 | .001 |
| 81.9% | 66.7% | −18.5 | .158 | 82.1% | 0.16 | .002 | 81.7% | −0.26 | .003 | 82.1% | 0.25 | .003 | |
| 68.1% | 44.8% | −34.3 | .233 | 68.3% | 0.45 | .004 | 67.9% | −3.49 | .003 | 68.2% | 0.59 | .005 | |
| 56.7% | 29.3% | −48.2 | .274 | 57.3% | 0.92 | .006 | 56.5% | −0.27 | .003 | 57.3% | 1.09 | .007 | |
| 10% | 95.2% | 91.0% | −4.48 | .043 | 95.2% | −0.01 | .002 | 95.1% | −0.29 | .003 | 95.4% | 0.10 | .002 |
| 82.1% | 67.9% | −17.4 | .142 | 82.3% | 0.17 | .002 | 81.6% | −0.69 | .006 | 82.5% | 0.49 | .006 | |
| 68.5% | 46.5% | −32.2 | .220 | 68.9% | 0.64 | .005 | 67.9% | −1.11 | .008 | 69.2% | 1.07 | .009 | |
| 56.4% | 30.3% | −46.2 | .261 | 57.1% | 1.33 | .008 | 55.6% | −1.36 | .008 | 57.4% | 1.84 | .011 | |
| 30% | 94.4% | 90.0% | −4.61 | .044 | 93.4% | −0.95 | .009 | 93.7% | −0.64 | .006 | 94.6% | 0.31 | .004 |
| 82.7% | 70.7% | −14.5 | .120 | 82.3% | −0.04 | .004 | 81.1% | −1.94 | .016 | 83.6% | 1.06 | .009 | |
| 69.4% | 50.9% | −26.8 | .186 | 69.7% | 0.42 | .005 | 67.1% | −3.33 | .023 | 70.9% | 2.17 | .016 | |
| 53.6% | 31.0% | −42.2 | .226 | 54.8% | 2.17 | .012 | 51.1% | −4.71 | .026 | 55.9% | 4.19 | .023 | |
| 50% | 93.2% | 89.5% | −3.97 | .037 | 88.3% | −0.53 | .049 | 91.2% | −2.08 | .020 | 93.9% | 0.80 | .008 |
| 77.6% | 67.2% | −13.4 | .105 | 74.6% | −3.79 | .030 | 72.5% | −6.58 | .051 | 79.9% | 3.00 | .024 | |
| 65.0% | 51.1% | −2.14 | .140 | 63.6% | 2.03 | .014 | 58.5% | −9.93 | .647 | 68.4% | 5.25 | .035 | |
| 46.6% | 31.3% | −32.8 | .153 | 47.8% | 0.03 | .014 | 40.0% | −14.0 | .066 | 51.3% | 10.0 | .005 | |
These results were compared to the true Person-time follow-up Rate (Eq. 3) based on complete information generated under the simulations, each averaged across 1000 simulated data sets. The simulations involved an assumed 5-year prospective cohort study of N = 1000 subjects with fixed annual interval clinical visits and non-informative dropout. Time-to-event was generated based on exponential distributions with event rates varied from 5 to 50% and time to dropout was generated based on an independent exponential distribution with dropout proportion varying from 10 to 70%. Results were averaged across the 1000 simulated datasets
Note: 1. % bias was calculated as (average of the particular method-η )/η *100%; 2. was calculated as the square root of the average of (estimate-η )2. MSE from the true η was calculated instead of variance because several methods used here can be biased
The follow-up rate at each annual interval after subjects (N = 610) in a retrospective cohort study of 3-year and 5-year prostate cancer (PrCa) recurrence risk based on electronic medical record (EMR) data
| Follow-upb | Nc | Percentage Method | Estimated follow-up using the formal method | Clark’s completeness index | Simplified Person-time Method |
|---|---|---|---|---|---|
| 1 Year | 558 | 91.4% | 95.7% | 95.5% | 95.7% |
| 2 Year | 472 | 86.2% | 95.0% | 94.5% | 95.0% |
| 3 Year | 383 | 80.9% | 93.6% | 92.9% | 93.8% |
| 4 Year | 295 | 75.6% | 92.5% | 92.3% | 93.3% |
| 5 Year | 197 | 67.5% | 91.8% | 91.8% | 93.0% |
Follow-up rates were estimated using four methods, namely, (i) the standard Percentage Method (Eq. 1 a), (ii) the formal Method (FPT, Eq. 4), (iii) the Clark’s completeness index (CCI, Eq. 2), and (iv) the Simplified Person-Time Method (SPT, Eq. 5)
aEquations are shown in the next
bA retrospective cohort study was conducted among incident PrCa patients who underwent robotic assisted laparoscopic prostatectomy (RALP) by a single surgeon at Montefiore Medical Center (MMC) in the Bronx from 10/2005 through 12/2012. These subjects were followed for disease recurrence or progression through December 2012. A total of N = 610 PrCa patients who underwent RALP and had their follow-up at MMC were included in this analysis
cWe calculated the follow-up rate at each year among the subset of the patients who had RALP early enough to be eligible for such length of follow-up. For example, to estimate the three year follow-up rate, we calculated this rate among the subjects who had RALP at least before 12/31/2009